Profession Notes

Biomedical Research Funding Government and private agencies are supporting biomedical research in the face of managed care cutbacks and changes in traditional funding. Forty-one medical schools will receive a total of $92 million over the next four years from the Howard Hughes Medical Institute (HHMI). The awards will help the schools find new ways to combine basic research and clinical treatment of patients, as well as support bioinformatics programs. This follows an $80 million award granted b

Written byNadia Halim
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Biomedical Research Funding

Government and private agencies are supporting biomedical research in the face of managed care cutbacks and changes in traditional funding. Forty-one medical schools will receive a total of $92 million over the next four years from the Howard Hughes Medical Institute (HHMI). The awards will help the schools find new ways to combine basic research and clinical treatment of patients, as well as support bioinformatics programs. This follows an $80 million award granted by HHMI in 1995 to 30 medical schools. Also recently, the National Cancer Institute awarded a $4.5 million grant to researchers at Case Western Reserve University's School of Medicine and University Hospitals of Cleveland. The five-year grant will support a project to uncover a new genetic link in the development of colon cancer. The National Institute of Allergy and Infectious Diseases has renewed funding for the Adult AIDS Clinical Trials Group (AACTG), the largest ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies